1. A comparison of two neurologic scoring instruments for multiple sclerosis

   • James A. Koziol
   • Adriana Frutos
   • Ernest Beutler

   Original Communication Pages: 209 - 213

2. Acyclovir treatment of relapsing-remitting multiple sclerosis

   • Jan Lycke
   • Bo Svennerholm
   • Oluf Andersen

   Original Communication Pages: 214 - 224

3. Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation

   • Elisabeth Andreadou
   • Christos Yapijakis
   • Constantinos Papageorgiou

   Original Communication Pages: 225 - 230

4. White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy

   • Patrick Vermersch
   • Jean Roche
   • Henri Petit

   Original Communication Pages: 231 - 234

5. International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease

   • Erik C. Wolters
   • International Sinemet CR Study Group
   • A. Williams

   Original Communication Pages: 235 - 240

6. Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke

   • Francesco Federico
   • Isabella Laura Simone
   • Carla Tortorella

   Original Communication Pages: 241 - 247

7. Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways

   • D. Caparros-Lefebvre
   • I. Girard-Buttaz
   • H. Petit

   Original Communication Pages: 248 - 256

8. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766

   • Gerlof D. Valk
   • Arnoud C. Kappelle
   • Frederik W. Bertelsmann

   Original Communication Pages: 257 - 263

9. Potential role of transforming growth factor-β1 in terminating the immune response in patients with Guillain-Barré syndrome

   • Eckhart Sindern
   • Klaus Schweppe
   • Jean Pierre Malin

   Original Communication Pages: 264 - 268

10. Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphate

    • Anna Czlonkowska
    • Jolanta Gajda
    • Maria Rodo

    Original Communication Pages: 269 - 273

11. The validity of a simple clinical classification of acute ischaemic stroke

    • J. M. Wardlaw
    • M. S. Dennis
    • C. P. Wadaw

    Original Communication Pages: 274 - 279

12. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

    • N. Thomson
    • P. Choudhary
    • R. M. Quinlivan

    Original Communication Pages: 280 - 285

13. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers

    • E. Gómez-Tortosa
    • A. del Barrio
    • P. J. García Ruiz

    Original Communication Pages: 286 - 292

14. Drug-induced parkinsonism: prevalence, clinical features and follow-up study in three Sicilian communities

    • Letterio Morgante
    • Antonio E. Di Rosa
    • Raoul Di Perri

    Letters to the Editors Pages: 293 - 301

15. Comments on “type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl”

    • Eiichiro Uyama
    • Makoto Uchino
    • Masayuki Ando

    Letter to the Editors Pages: 295 - 297

16. Characterization of basal ganglia dysfunction in Leber ‘plus’ disease

    • C. O. Hanemann
    • H. Hefter
    • R. Benecke

    Letter to the Editors Pages: 297 - 300

17. Pathological yawning as a symptom of multiple sclerosis

    • T. Postert
    • D. Pöhlau
    • H. Przuntek

    Letter to the Editors Pages: 300 - 301

18. Announcement

    Announcement Pages: 302 - 302